Gb Sciences Addresses Growing Need for Anxiety and Depressio

12.12.2022 - As mental health disorders increasingly impact global populations, Gb Sciences is developing psychotropic but non-psychedelic treatments for anxiety and depression that compete with the emerging billion-dollar psychedelic companies.LAS VEGAS, Dec. ... Seite 1

Related Keywords

, Gb Sciences , Gb Sciences Inc , Phytomedical Analytics For Research Optimization At Scale , Andrea Small Howard , Chief Science Officer , Phytomedical Analytics , Research Optimization ,